News & Announcements

Weil Advises PSG Portfolio Company Loopback Analytics in Assumption of Limited Distribution Drug Access Services from Acentrus Specialty

Weil advised PSG portfolio company Loopback Analytics in the assumption of the Limited Distribution Drug Access (LDD) clients and services of Acentrus Specialty.

Loopback has been working with Acentrus Specialty, an LDD program offered by Vizient, Inc., through a strategic partnership with Vizient since 2018. Loopback provides data management, analytics, and services to over 40 health systems to enable its clients to grow their specialty pharmacy business and track clinical outcomes.

Acentrus Specialty is the nation’s largest specialty pharmacy network, serving 142 health systems. Loopback Analytics is a leading provider of data analytics and insights that simplify understanding, access and innovation for patients requiring specialty care.

The Weil team was led by Private Equity partner Emily Willey and included Private Equity partner David Gail.